Photo by starofthesea7 from unsplash
Immunosuppressive (IS) therapy after lung transplantation (LTx) remains a matter of controversy. Treatment regimens and concepts vary significantly between centers worldwide. Although there is a broad consensus on a triple… Click to show full abstract
Immunosuppressive (IS) therapy after lung transplantation (LTx) remains a matter of controversy. Treatment regimens and concepts vary significantly between centers worldwide. Although there is a broad consensus on a triple IS therapy, protocols differ by the preferred calcineurin inhibitor (CNI) [cyclosporine A (CsA) vs. tacrolimus], cell cycle inhibitor [mycophenolate mofetil (MMF) vs. azathioprine] and induction therapy (basiliximab, ATG, alemtuzumab, no induction).
Keywords:
search holy;
immunosuppression lung;
lung transplantation;
transplantation search;
lung
Journal Title: Journal of thoracic disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of thoracic disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!